Charles Schwab’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $98.5M | Buy |
1,246,322
+2,707
| +0.2% | +$230K | 0.01% | 804 |
|
|
2026
Q1 | $107M | Buy |
1,243,615
+52,998
| +4% | +$4.76M | 0.02% | 687 |
|
|
2025
Q4 | $104M | Sell |
1,190,617
-13,091
| -1% | -$994K | 0.02% | 716 |
|
|
2025
Q3 | $68.9M | Buy |
1,203,708
+24,848
| +2% | +$1.43M | 0.01% | 940 |
|
|
2025
Q2 | $69.6M | Sell |
1,178,860
-9,270
| -0.8% | -$599K | 0.01% | 886 |
|
|
2025
Q1 | $87M | Sell |
1,188,130
-33,085
| -3% | -$2.73M | 0.02% | 720 |
|
|
2024
Q4 | $101M | Sell |
1,221,215
-17,388
| -1% | -$1.37M | 0.02% | 664 |
|
|
2024
Q3 | $88.6M | Buy |
1,238,603
+285,172
| +30% | +$20.1M | 0.02% | 730 |
|
|
2024
Q2 | $65.3M | Sell |
953,431
-31,099
| -3% | -$1.86M | 0.01% | 877 |
|
|
2024
Q1 | $52.8M | Sell |
984,530
-23,282
| -2% | -$1.25M | 0.01% | 1007 |
|
|
2023
Q4 | $53.7M | Buy |
1,007,812
+60,060
| +6% | +$2.93M | 0.01% | 929 |
|
|
2023
Q3 | $47.1M | Buy |
947,752
+380,081
| +67% | +$21.3M | 0.01% | 911 |
|
|
2023
Q2 | $33.8M | Buy |
567,671
+17,268
| +3% | +$984K | 0.01% | 1140 |
|
|
2023
Q1 | $31.2M | Buy |
550,403
+8,659
| +2% | +$555K | 0.01% | 1154 |
|
|
2022
Q4 | $40.2M | Buy |
541,744
+10,870
| +2% | +$740K | 0.01% | 957 |
|
|
2022
Q3 | $31.6M | Buy |
530,874
+11,759
| +2% | +$708K | 0.01% | 1060 |
|
|
2022
Q2 | $29.1M | Sell |
519,115
-21,443
| -4% | -$1.41M | 0.01% | 1115 |
|
|
2022
Q1 | $39.9M | Sell |
540,558
-37,032
| -6% | -$2.57M | 0.01% | 1031 |
|
|
2021
Q4 | $41.7M | Buy |
577,590
+32,902
| +6% | +$2.39M | 0.01% | 1026 |
|
|
2021
Q3 | $41.7M | Buy |
544,688
+51,048
| +10% | +$4.1M | 0.01% | 999 |
|
|
2021
Q2 | $38.3M | Buy |
493,640
+18,193
| +4% | +$1.29M | 0.01% | 1066 |
|
|
2021
Q1 | $29.3M | Buy |
475,447
+20,203
| +4% | +$1.28M | 0.01% | 1214 |
|
|
2020
Q4 | $29.7M | Buy |
455,244
+8,517
| +2% | +$490K | 0.01% | 1116 |
|
|
2020
Q3 | $22.1M | Sell |
446,727
-7,006
| -2% | -$361K | 0.01% | 1139 |
|
|
2020
Q2 | $21.6M | Sell |
453,733
-135,618
| -23% | -$6.54M | 0.01% | 1112 |
|
|
2020
Q1 | $25.1M | Buy |
589,351
+17,399
| +3% | +$860K | 0.01% | 856 |
|
|
2019
Q4 | $33.7M | Buy |
571,952
+11,128
| +2% | +$604K | 0.02% | 870 |
|
|
2019
Q3 | $28.7M | Sell |
560,824
-15,636
| -3% | -$745K | 0.02% | 921 |
|
|
2019
Q2 | $24.4M | Buy |
576,460
+17,701
| +3% | +$769K | 0.01% | 1004 |
|
|
2019
Q1 | $27.6M | Buy |
558,759
+56,242
| +11% | +$2.54M | 0.02% | 909 |
|
|
2018
Q4 | $21.7M | Buy |
502,517
+21,541
| +4% | +$1.07M | 0.02% | 946 |
|
|
2018
Q3 | $27.3M | Buy |
480,976
+37,653
| +8% | +$1.98M | 0.02% | 933 |
|
|
2018
Q2 | $22.4M | Buy |
443,323
+21,548
| +5% | +$1.12M | 0.02% | 998 |
|
|
2018
Q1 | $21M | Buy |
421,775
+31,253
| +8% | +$1.47M | 0.02% | 969 |
|
|
2017
Q4 | $16.1M | Buy |
390,522
+43,747
| +13% | +$1.53M | 0.01% | 1150 |
|
|
2017
Q3 | $10.3M | Buy |
346,775
+22,922
| +7% | +$700K | 0.01% | 1408 |
|
|
2017
Q2 | $10.7M | Buy |
323,853
+31,452
| +11% | +$988K | 0.01% | 1304 |
|
|
2017
Q1 | $8.66M | Buy |
292,401
+15,501
| +6% | +$423K | 0.01% | 1411 |
|
|
2016
Q4 | $6.87M | Buy |
276,900
+14,304
| +5% | +$325K | 0.01% | 1529 |
|
|
2016
Q3 | $5.93M | Buy |
262,596
+4,720
| +2% | +$111K | 0.01% | 1532 |
|
|
2016
Q2 | $6.15M | Buy |
257,876
+5,388
| +2% | +$129K | 0.01% | 1432 |
|
|
2016
Q1 | $6M | Buy |
252,488
+19,347
| +8% | +$473K | 0.01% | 1400 |
|
|
2015
Q4 | $6.49M | Buy |
233,141
+14,084
| +6% | +$354K | 0.01% | 1333 |
|
|
2015
Q3 | $4.53M | Sell |
219,057
-20,370
| -9% | -$516K | 0.01% | 1539 |
|
|
2015
Q2 | $6.15M | Buy |
239,427
+6,046
| +3% | +$153K | 0.01% | 1413 |
|
|
2015
Q1 | $5.89M | Sell |
233,381
-16,694
| -7% | -$407K | 0.01% | 1394 |
|
|
2014
Q4 | $5.95M | Sell |
250,075
-131,528
| -34% | -$2.91M | 0.01% | 1315 |
|
|
2014
Q3 | $7.51M | Buy |
381,603
+164,721
| +76% | +$3.39M | 0.01% | 1029 |
|
|
2014
Q2 | $5.19M | Buy |
216,882
+63,622
| +42% | +$1.53M | 0.01% | 1364 |
|
|
2014
Q1 | $4.08M | Buy |
153,260
+9,234
| +6% | +$219K | 0.01% | 1494 |
|
|
2013
Q4 | $2.91M | Buy |
144,026
+5,394
| +4% | +$100K | 0.01% | 1667 |
|
|
2013
Q3 | $2.43M | Buy |
138,632
+45,248
| +48% | +$783K | ﹤0.01% | 1732 |
|
|
2013
Q2 | $1.55M | Buy |
+93,384
| New | +$1.44M | ﹤0.01% | 1914 |
|
Other funds holding GMED
JT
SC
Charles Schwab's GMED Position: Q2 2026 in Review
Charles Schwab increased its Globus Medical (GMED) stake by 0.22% in Q2 2026, buying an estimated $230K and bringing the position to 1,246,322 shares worth $98.5M. The position accounts for 0.01% of the portfolio, ranked #804.
Charles Schwab first reported a position in GMED in Q2 2013 and has held it in 53 quarters since. The position peaked at $107M in Q1 2026. 594 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Charles Schwab held 1,246,322 shares of Globus Medical worth $98.5M as of Q2 2026.
- Charles Schwab bought 2,707 Globus Medical shares in Q2 2026, an estimated $230K.
- Globus Medical made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #804 holding.
- Charles Schwab first reported a position in Globus Medical in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Globus Medical position peaked at $107M in Q1 2026.
- 594 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.